Media Inquiries

Meredith Kaya

Vice President, Investor Relations and Corporate Communications

617.374.5082

mkaya@ironwoodpharma.com

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

bcalitri@ironwoodpharma.com
Sort by Year
May 1, 2018

Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update

May 1, 2018

Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action

April 17, 2018

Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call

April 9, 2018

Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital

March 5, 2018

Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences

February 15, 2018

Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update

February 1, 2018

Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Investor Update Call

January 16, 2018

Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS® (linaclotide) Patent Litigation

January 2, 2018

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

December 21, 2017

Ironwood Pharmaceuticals Initiates Phase II Clinical Trial of sGC Stimulator IW-1701 in Patients with Sickle Cell Disease

December 4, 2017

Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects

November 28, 2017

Ironwood Pharmaceuticals Strengthens Executive Leadership Team

November 2, 2017

Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update

November 1, 2017

Ironwood Pharmaceuticals to Present at Credit Suisse 26th Annual Healthcare Conference

October 30, 2017

Ironwood Highlights Breadth of Gout Research to be Presented at the 2017 ACR/ARHP Annual Meeting

Copyright © 2020, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.